Number of Shares
1.13 Mil
Current Holdings Value*
$7.12 Mil
% of Portfolio
8.37%
Total Estimate Gain
$27,841.48
% of Total Estimate Gain
0.28%

Propel Bio Management, LLC's Phathom Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Propel Bio Management, LLC held 1.13 Mil shares of Phathom Pharmaceuticals Inc(PHAT), totaling $7.12 Mil. This investment constitutes 8.37% of their stock portfolio, and Propel Bio Management, LLC now holds 1.63% of the outstanding Phathom Pharmaceuticals Inc(PHAT) stock.

The initial trade took place in 2023Q4. And since then Propel Bio Management, LLC has made 3 purchases of PHAT, at an average price of $8.64, for a total of 1.13 Mil shares. Based on historical transaction data and PHAT's current price of $8.66, Propel Bio Management, LLC's estimated gain on his PHAT holdings is $27,841.48, reflecting a 0.28% gain to date.

Propel Bio Management, LLC PHAT ($8.66) Holding Chart

Propel Bio Management, LLC PHAT ($8.66) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1